Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Efficiency assessment of a complementary feed for dogs with chronic joint disorders during 8 weeks of administration: an open-label field study
Navarro C., Nicolas C.
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Read
Osteoarthritis is a common degenerative disorder in ageing dogs. The objective of this study was to investigate the efficiency of a feed supplement intended to support joint function (Fortiflex®, Virbac, Carros, France), in dogs with mobility impairments.
Dogs with mobility disorders for at least 3 months and with no treatment for at least 2 months before the study start were included. They had alterations of at least 3 of these 7 parameters (scored from 1 (normal) to 4 (serious alteration)): interactions with people; rise from lying down; walk or run; lameness; walk on stairs; play; or jump on bed/coach/ car. Dogs were given the feed supplement once daily for 8 weeks and parameters were evaluated at W2, W4 and W8. The difficulties to rise; walk or run; walk on stairs; play; and jump were also rated from 0 (no difficulty) to 10 (extremely difficult) at initiation and end of administration (W8). A Friedman test was used to evaluate the changes of parameters over time and a comparison between each time point and baseline was done using a Wilcoxon signed-rank test.
Sixty-one dogs, with an average age and weight of 12 years and 18.7 kg were included and analysed. All 7 mobility scores were significantly improved during the study period (p<0.05). Some of them were significantly improved after only 2 weeks of administration. All marks given for the 5 difficulties rated, decreased significantly from Day 0 to W8, except for the difficulty to play. According to pet owners, the mobility of dogs was improved by 74% at the end of the study period. The product was well accepted by the dogs (mean note= 8.30/10). No serious adverse events were recorded during the study.
This feed supplement improved joint functions of dogs and can be used safely in dogs with mobility disorders.
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Comments (0)
Ask the author
0 comments